日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

接种二价信使RNA严重急性呼吸综合征冠状病毒2疫苗加强免疫后的黏膜和全身抗体反应

Atmar, Robert L; Lyke, Kirsten E; Posavad, Christine M; Deming, Meagan E; Brady, Rebecca C; Dobrzynski, David; Edupuganti, Srilatha; Mulligan, Mark J; Rupp, Richard E; Rostad, Christina A; Jackson, Lisa A; Martin, Judith M; Shriver, Mallory C; Rajakumar, Kumaravel; Coler, Rhea N; El Sahly, Hana M; Kottkamp, Angelica C; Branche, Angela R; Frenck, Robert W; Johnston, Christine; Babu, Tara M; Bäcker, Martín; Archer, Janet I; Crandon, Sonja; Nakamura, Aya; Nayak, Seema U; Szydlo, Daniel; Dominguez Islas, Clara P; Brown, Elizabeth R; O'Connell, Sarah E; Montefiori, David C; Eaton, Amanda; Neuzil, Kathleen M; Stephens, David S; Beigel, John H; Pasetti, Marcela; Roberts, Paul C

Correction for Oom et al., "The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response"

对 Oom 等人的论文“两剂 MVA-BN 痘苗疫苗诱导的 MPXV 特异性抗体反应不持久且亲和力低”的更正

Oom, Aaron L; Wilson, Kesi K; Yonatan, Miilani; Rettig, Stephanie; Youn, Heekoung Allison; Tuen, Michael; Shah, Yusra; DuMont, Ashley L; Belli, Hayley M; Zucker, Jane R; Rosen, Jennifer B; Herati, Ramin Sedaghat; Samanovic, Marie I; Duerr, Ralf; Kottkamp, Angelica C; Mulligan, Mark J

A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults

一项评估核苷修饰的信使RNA流感疫苗在健康成人中安全性、耐受性和免疫原性的1/2期随机研究

Branche, Angela; Mulligan, Mark J; Maniar, Alok; Puente, Orlando; Oladipupo, Islamiat; Crowther, Graham; Zareba, Agnieszka M; Yi, Zhuobiao; Scully, Ingrid; Gomme, Emily; Koury, Kenneth; Kitchin, Nicholas; Allen, Pirada Suphaphiphat; Anderson, Annaliesa S; Gurtman, Alejandra; Lindert, Kelly

Megakaryocyte phenotyping in response to SARS-CoV-2 variants

巨核细胞对SARS-CoV-2变异株的表型反应

Sowa, Marcin A; Tuen, Michael; Schlamp, Florencia; Xia, Yuhe; Samanovic, Marie I; Mulligan, Mark J; Barrett, Tessa J

Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial

延迟加强接种rVSVΔG-ZEBOV-GP疫苗预防埃博拉病毒病的安全性和免疫原性:一项多中心、开放标签、II期随机对照试验

Davey, Richard T Jr; Collins, Gary L; Rouphael, Nadine; Poliquin, Guillaume; McConnell, Rosemary; Grubbs, Gabrielle; Moir, Susan L; Langley, Joanne M; Teitelbaum, Marc; Hewlett, Angela L; McLellan, Susan L F; Bhadelia, Nahid; Raabe, Vanessa N; Mulligan, Mark J; Maljkovic Berry, Irina; Dighero-Kemp, Bonnie; Kurtz, Jonathan R; Hensley, Lisa E; Dozier, Nelson C E; Marron, Lindsay C B; DuChene, Alain; Kuhn, Jens H; Brown, Shawn K; Khurana, Surender; Lane, H Clifford; Neaton, James D

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

作者更正:一项国际合作开展的随机试验荟萃分析显示,羟氯喹和氯喹治疗 COVID-19 的死亡率结果

Axfors, Cathrine; Schmitt, Andreas M; Janiaud, Perrine; Van't Hooft, Janneke; Abd-Elsalam, Sherief; Abdo, Ehab F; Abella, Benjamin S; Akram, Javed; Amaravadi, Ravi K; Angus, Derek C; Arabi, Yaseen M; Azhar, Shehnoor; Baden, Lindsey R; Baker, Arthur W; Belkhir, Leila; Benfield, Thomas; Berrevoets, Marvin A H; Chen, Cheng-Pin; Chen, Tsung-Chia; Cheng, Shu-Hsing; Cheng, Chien-Yu; Chung, Wei-Sheng; Cohen, Yehuda Z; Cowan, Lisa N; Dalgard, Olav; de Almeida E Val, Fernando F; de Lacerda, Marcus V G; de Melo, Gisely C; Derde, Lennie; Dubee, Vincent; Elfakir, Anissa; Gordon, Anthony C; Hernandez-Cardenas, Carmen M; Hills, Thomas; Hoepelman, Andy I M; Huang, Yi-Wen; Igau, Bruno; Jin, Ronghua; Jurado-Camacho, Felipe; Khan, Khalid S; Kremsner, Peter G; Kreuels, Benno; Kuo, Cheng-Yu; Le, Thuy; Lin, Yi-Chun; Lin, Wu-Pu; Lin, Tse-Hung; Lyngbakken, Magnus Nakrem; McArthur, Colin; McVerry, Bryan J; Meza-Meneses, Patricia; Monteiro, Wuelton M; Morpeth, Susan C; Mourad, Ahmad; Mulligan, Mark J; Murthy, Srinivas; Naggie, Susanna; Narayanasamy, Shanti; Nichol, Alistair; Novack, Lewis A; O'Brien, Sean M; Okeke, Nwora Lance; Perez, Léna; Perez-Padilla, Rogelio; Perrin, Laurent; Remigio-Luna, Arantxa; Rivera-Martinez, Norma E; Rockhold, Frank W; Rodriguez-Llamazares, Sebastian; Rolfe, Robert; Rosa, Rossana; Røsjø, Helge; Sampaio, Vanderson S; Seto, Todd B; Shahzad, Muhammad; Soliman, Shaimaa; Stout, Jason E; Thirion-Romero, Ireri; Troxel, Andrea B; Tseng, Ting-Yu; Turner, Nicholas A; Ulrich, Robert J; Walsh, Stephen R; Webb, Steve A; Weehuizen, Jesper M; Velinova, Maria; Wong, Hon-Lai; Wrenn, Rebekah; Zampieri, Fernando G; Zhong, Wu; Moher, David; Goodman, Steven N; Ioannidis, John P A; Hemkens, Lars G

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults

一项评估不同加强免疫方案的 2013 年和 2017 年 A(H7N9) 灭活流感病毒疫苗在健康美国成年人中安全性、反应原性和免疫原性的 II 期临床试验,疫苗分别添加和不添加 AS03 佐剂。

Rostad, Christina A; Atmar, Robert L; Walter, Emmanuel B; Frey, Sharon; Meier, Jeffery L; Sherman, Amy C; Lai, Lilin; Tsong, Rachel; Kao, Carol M; Raabe, Vanessa; El Sahly, Hana M; Keitel, Wendy A; Whitaker, Jennifer A; Smith, Michael J; Schmader, Kenneth E; Swamy, Geeta K; Abate, Getahun; Winokur, Patricia; Buchanan, Wendy; Cross, Kaitlyn; Wegel, Ashley; Xu, Yongxian; Yildirim, Inci; Kamidani, Satoshi; Rouphael, Nadine; Roberts, Paul C; Mulligan, Mark J; Anderson, Evan J

Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials

异源性 cAd3-Ebola 和 MVA-EbolaZ 疫苗在美国和乌干达的 1/1b 期临床试验中显示出安全性和免疫原性。

Happe, Myra; Hofstetter, Amelia R; Wang, Jing; Yamshchikov, Galina V; Holman, LaSonji A; Novik, Laura; Strom, Larisa; Kiweewa, Francis; Wakabi, Salim; Millard, Monica; Kelley, Colleen F; Kabbani, Sarah; Edupuganti, Srilatha; Beck, Allison; Kaltovich, Florence; Murray, Tamar; Tsukerman, Susanna; Carr, Derick; Ashman, Carl; Stanley, Daphne A; Ploquin, Aurélie; Bailer, Robert T; Schwartz, Richard; Cham, Fatim; Tindikahwa, Allan; Hu, Zonghui; Gordon, Ingelise J; Rouphael, Nadine; Houser, Katherine V; Coates, Emily E; Graham, Barney S; Koup, Richard A; Mascola, John R; Sullivan, Nancy J; Robb, Merlin L; Ake, Julie A; Lyke, Kirsten E; Mulligan, Mark J; Ledgerwood, Julie E; Kibuuka, Hannah

Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants

孕妇接种新冠病毒疫苗与预防婴儿出现症状的感染

Cardemil, Cristina V; Cao, Yi; Posavad, Christine M; Badell, Martina L; Bunge, Katherine; Mulligan, Mark J; Parameswaran, Lalitha; Olson-Chen, Courtney; Novak, Richard M; Brady, Rebecca C; DeFranco, Emily; Gerber, Jeffrey S; Pasetti, Marcela; Shriver, Mallory; Coler, Rhea; Berube, Bryan; Suthar, Mehul S; Moreno, Alberto; Gao, Fei; Richardson, Barbra A; Beigi, Richard; Brown, Elizabeth; Neuzil, Kathleen M; Munoz, Flor M

Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo

用于评估体内结核病免疫力的卡介苗人体感染模型开发的1期开放标签剂量递增试验

Blazevic, Azra; Edwards, Rachel L; Xia, Mei; Eickhoff, Christopher S; Hamzabegovic, Fahreta; Meza, Krystal A; Ning, Huan; Tennant, Janice; Mosby, Karla J; Ritchie, James C; Girmay, Tigisty; Lai, Lilin; McCullough, Michele; Beck, Allison; Kelley, Colleen; Edupuganti, Srilatha; Kabbani, Sarah; Buchanan, Wendy; Makhene, Mamodikoe K; Voronca, Delia; Cherikh, Sami; Goll, Johannes B; Rouphael, Nadine G; Mulligan, Mark J; Hoft, Daniel F